ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,164Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 387

$667K Total Retail Price of All Prescriptions

Rank: 83 out of 387

533 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
12% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

14% of this provider’s 533 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 15,281 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
SIMVASTATIN 874 806 1 5
LISINOPRIL 742 711 2 3
LEVOTHYROXINE SODIUM 617 591 3 2
AMLODIPINE BESYLATE 585 569 4 6
OMEPRAZOLE 498 470 5 4
FUROSEMIDE 451 403 6 7
WARFARIN SODIUM 438 420 7 17
POTASSIUM CHLORIDE 367 350 8 9
HYDROCODONE-ACETAMINOPHEN 322 300 S3 9 1
ATENOLOL 318 314 10 20
LOVASTATIN 309 292 11 36
TRIAMTERENE-HCTZ 307 294 12 55
METOPROLOL SUCCINATE 294 283 13 18
ZOLPIDEM TARTRATE 267 247 14 16
ATORVASTATIN CALCIUM 259 245 15 13
FENOFIBRATE 250 241 16 106
PRAVASTATIN SODIUM 240 235 17 15
METOPROLOL TARTRATE 237 235 18 11
VERAPAMIL ER 207 189 19 87
ALENDRONATE SODIUM 186 183 20 31
CITALOPRAM HBR 185 168 21 19
METFORMIN HCL 171 163 22 8
DONEPEZIL HCL 165 165 23 27
METFORMIN HCL ER 159 152 24 81
GLIMEPIRIDE 159 154 24 50
BENAZEPRIL HCL 146 145 26 86
PANTOPRAZOLE SODIUM 145 128 27 48
HYDROCHLOROTHIAZIDE 144 143 28 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 138 127 29 30
TERAZOSIN HCL 138 134 29 109
CLONIDINE HCL 136 134 31 38
DOXAZOSIN MESYLATE 134 134 32 75
LOSARTAN POTASSIUM 134 132 32 24
CARVEDILOL 123 105 34 21
DIGOXIN 122 119 35 40
ALLOPURINOL 117 117 36 28
CLOPIDOGREL 110 102 37 25
TRAMADOL HCL 109 109 38 14
TAMSULOSIN HCL 107 105 39 32
GLIPIZIDE 106 105 40 63
DILTIAZEM 24HR CD 102 102 41 118
KLOR-CON 10 98 66 42 124
AMLODIPINE BESYLATE-BENAZEPRIL 97 87 43 54
GABAPENTIN 93 85 44 10
PLAVIX 88 86 45 39
DIOVAN 88 88 45 33
LEVOFLOXACIN 85 82 47 84
ADVAIR DISKUS 83 72 48 41
AMITRIPTYLINE HCL 82 82 R 49 62
FINASTERIDE 81 81 50 95
CRESTOR 80 80 51 34
FLUOXETINE HCL 77 66 52 46
FLUTICASONE PROPIONATE 72 69 53 29
ROPINIROLE HCL 72 66 53 91
MELOXICAM 72 72 53 22
KLOR-CON M10 70 70 56 149
JANTOVEN 69 69 57 170
LANTUS 69 69 57 51
PREMARIN 67 67 R 59 77
AMIODARONE HCL 66 60 60 156
PAROXETINE HCL 66 55 60 52
CELEBREX 65 65 62 72
PREDNISONE 61 55 63 43
NADOLOL 57 57 64 261
GLIPIZIDE XL 56 56 65 232
RANITIDINE HCL 55 44 66 45
SERTRALINE HCL 53 53 67 23
PHENYTOIN SODIUM EXTENDED 51 51 68 107
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 29, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.